Parasitosis regionales - Biblioteca central de la Universidad ...

Sixto Raúl Costamagna y Elena C. Visciarelli (Compiladores)
Meyer ZBC, Cramer S, Trumpfheller C, Fleischer B and Frosch S. 1997. Trypanosoma
cruzi induces strong IL-12 and IL-18 gene expression in vivo: correlation with interferon-gamma
(INF??) production. Clin. Exp. Immunol, 110: 378-85.
Miles MA y col. 1977 The identification by isoenzyme patterns of two distinct straingroups
of Trypanosoma cruzi, circulating independently in a rural area of Brazil. Trans
R Soc Trop Med Hyg, 71: 217-225.
Moncayo A. 1994. Iniciativa de los Países del Cono Sur. Acta Toxicol. Argent., 2:
34-35.
Morello A. 1988. The biochemistry of the mode of action of drugs and the detoxication
mechanisms in Trypanosoma cruzi. Comp. Biochem. Physiol., 90 C: 1-12.
Morris S, Tanowitz H, Wittner M and Bilezikian J. 1990. Pathophysiological insights
into the cardiomyophaty of Chagas’ disease. Circulation, 82: 1900-1909.
Mosmann TR, Cherwinsky H, Bond MW, Giedlin MA y Coffman RL. 1986. Two Types
of murine T cell clones. I. Definition according to profiles of lymphokine activities
and secreted proteins. J. Immunol, 136: 2348-2355
Moya PR, Paolasso R D, Blanco, Lapasset M, Sanmartino C, Baso B, Moretti E, Cura D,
1985. Tratamiento de la Enfermedad de Chagas con Nifurtimox durante los primeros
meses de vida. Medicina (Buenos Aires), 45: 553-558,.
Moser DR, Kirchhoff LV and Donelson JE. 1989. Detection of Trypanosoma cruzi by
DNA amplification using the polymerase chain reaction. J. Clin. Microbiol., 27:1477-
1482.
Mullis KB. 1987.Specific synthesis of DNA in vitro via a polymerase-catalyzed chain
reaction. Methods Enzymol, 155: 335.
Muñoz-Fernández MA, Fernández MA and Fresno M. 1992. Synergism between tumor
necrosis factor-? and Interferon-? on macrophage activation for the killing of
intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur. J.
Immunol., 22: 301-307.
64